Walgreens has sold more shares of drug distributor Cencora for proceeds of about $300 million in the latest effort to pay ...

U.S. drugstore chain Walgreens Boots Alliance said on Thursday it has sold more shares in drug distributor Cencora for ...

在公司内部方面，Cencora宣布两位资深董事会成员Richard W. Gochnauer和Kathleen W. Hyle退休。这一变动将使董事会规模从13人减少到11人。此外，Cencora已完成对Retina Consultants of America的收购，并上调了2025财年调整后每股收益指引。

The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10 ...

在全球药品市场逐渐回暖的背景下，2023年2月7日，十字路口的沃尔格林联合博姿（Walgreens Boots Alliance）宣布，已经完成对药品分销商Cencora股份的再次出售，共计套现约3亿美元。这一举动不仅令市场为之一振，也引发了各界对沃尔格林未来战略的热烈讨论。令人好奇的是，这笔交易究竟意味着什么？背后又隐藏着怎样的商业逻辑和资本运作？本篇文章将对此进行深入剖析。

在最新的市场动态中，美国药品零售巨头沃尔格林联合博姿（Walgreens Boots ...

Walgreens Boots Alliance, Inc. (NASDAQ:WBA), through its subsidiary Walgreens Boots Alliance Holdings LLC, recently reported significant stock transactions involving Cencora, Inc. (NYSE:COR), a ...

In yet another move to pay down debt that matures in 2026, Walgreens Boots Alliance announced last night it would receive ...

Feb 6 (Reuters) - U.S. drugstore chain Walgreens Boots Alliance (WBA.O), opens new tab said on Thursday it has sold more shares in drug distributor Cencora (COR.N), opens new tab for proceeds of ...

(Reuters) - U.S. drugstore chain Walgreens Boots Alliance said on Thursday it has sold more shares in drug distributor Cencora for proceeds of about $300 million. The company said that it now owns ...

Walgreens is offloading more shares in drug distributor Cencora as the struggling pharmacy chain looks to generate cash. The latest sale netted about $300 million for Walgreens, and shrinks the ...